Cargando…

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disease characterized by biological and clinical heterogeneity. The interleukin (IL)-1 superfamily is a group of innate cytokines that contribute to pathogenesis in many autoimmune diseases. IL-1β and IL-18 are two members that h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mende, Rachel, Vincent, Fabien B., Kandane-Rathnayake, Rangi, Koelmeyer, Rachel, Lin, Emily, Chang, Janet, Hoi, Alberta Y., Morand, Eric F., Harris, James, Lang, Tali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999794/ https://www.ncbi.nlm.nih.gov/pubmed/29930551 http://dx.doi.org/10.3389/fimmu.2018.01250

Ejemplares similares

Analysis of serum interleukin(IL)‐1α, IL‐1β and IL‐18 in patients with systemic sclerosis
por: Lin, Emily, et al.
Publicado: (2019)

Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus
por: Godsell, Jack, et al.
Publicado: (2016)

Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis
por: Northcott, Melissa, et al.
Publicado: (2022)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020)

Analysis of serum B cell‐activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2019)

Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2018)

Clinical associations of cognitive dysfunction in systemic lupus erythematosus
por: Raghunath, Sudha, et al.
Publicado: (2023)

Analysis of serum macrophage migration inhibitory factor and D‐dopachrome tautomerase in systemic sclerosis
por: Vincent, Fabien B, et al.
Publicado: (2018)

Fibromyalgia, mood disorders, cognitive test results, cognitive symptoms and quality of life in systemic lupus erythematosus
por: Raghunath, Sudha, et al.
Publicado: (2022)

Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythematosus: a longitudinal study
por: Louthrenoo, Worawit, et al.
Publicado: (2020)

Clinical associations of serum interleukin-17 in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2013)

Novel Methods of Incorporating Time in Longitudinal Multivariate Analysis Reveals Hidden Associations With Disease Activity in Systemic Lupus Erythematosus
por: Nim, Hieu T., et al.
Publicado: (2019)

Independent association of glucocorticoids with damage accrual in SLE
por: Apostolopoulos, Diane, et al.
Publicado: (2016)

Immunosuppressant exposure confounds gene expression analysis in systemic lupus erythematosus
por: Northcott, Melissa, et al.
Publicado: (2022)

Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus
por: Connelly, K. L., et al.
Publicado: (2016)

Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus
por: Connelly, K. L., et al.
Publicado: (2018)

High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus
por: Koelmeyer, Rachel, et al.
Publicado: (2020)

The performance of different classification criteria for systemic lupus erythematosus in a real-world rheumatology department
por: Tan, Brandon C H, et al.
Publicado: (2022)

Cardiovascular risk profiles in a lupus cohort: what do different calculators tell us?
por: Boulos, Daniel, et al.
Publicado: (2017)

A potential association between IL‐3 and type I and III interferons in systemic lupus erythematosus
por: Oon, Shereen, et al.
Publicado: (2019)

Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational study
por: Kandane-Rathnayake, Rangi, et al.
Publicado: (2021)

MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus
por: Lang, Tali, et al.
Publicado: (2015)

IL-17 in Systemic Lupus Erythematosus
por: Crispín, José C., et al.
Publicado: (2010)

IL-10 revisited in systemic lupus erythematosus
por: Biswas, Swayanka, et al.
Publicado: (2022)

Interleukin-18 and IL-18 Binding Protein
por: Dinarello, Charles A., et al.
Publicado: (2013)

Anti-IL-10 antibody in systemic lupus erythematosus
por: Uchida, Marina, et al.
Publicado: (2019)

Interleukin-1β (IL-1β) & IL-4 gene polymorphisms in patients with systemic lupus erythematosus (SLE) & their association with susceptibility to SLE
por: Mohammadoo-khorasani, Milad, et al.
Publicado: (2016)

Editorial: Focus on Systemic Lupus Erythematosus
por: Harris, James, et al.
Publicado: (2016)

Disease course following High Disease Activity Status revealed patterns in SLE
por: Hoi, Alberta, et al.
Publicado: (2021)

Association of clinic setting with quality indicator performance in systemic lupus erythematosus: a cross-sectional study
por: Sreedharan, Sidha, et al.
Publicado: (2022)

‘Not at target’: prevalence and consequences of inadequate disease control in systemic lupus erythematosus—a multinational observational cohort study
por: Kandane-Rathnayake, Rangi, et al.
Publicado: (2022)

Role of Serum IL‐6 in Neuropsychiatric Systemic lupus Erythematosus
por: Hirohata, Shunsei, et al.
Publicado: (2021)

Involvement of IL-33 in the Pathophysiology of Systemic Lupus Erythematosus: Review
por: Sarrand, Julie, et al.
Publicado: (2022)

Prophylactic and Therapeutic Effects of Interleukin-2 (IL-2)/Anti-IL-2 Complexes in Systemic Lupus Erythematosus-Like Chronic Graft-Versus-Host Disease
por: Heiler, Stefan, et al.
Publicado: (2018)

Interleukin-18, Functional IL-18 Receptor and IL-18 Binding Protein Expression in Active and Latent Tuberculosis
por: Wawrocki, Sebastian, et al.
Publicado: (2020)

Longitudinal comparison of IL-6, IL-10, and IL-12 cytokine profiles in adult and childhood-onset systemic lupus erythematosus
por: Peliçari, Karina de Oliveira, et al.
Publicado: (2022)

Involvement of lncRNA IL21-AS1 in interleukin-2 and T follicular regulatory cell activation in systemic lupus erythematosus
por: Hao, He, et al.
Publicado: (2021)

Hypomethylation of IL10 and IL13 Promoters in CD4(+) T Cells of Patients with Systemic Lupus Erythematosus
por: Zhao, Ming, et al.
Publicado: (2010)

Association of IL-18 polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Asian populations: a meta-analysis
por: Chen, Shuilian, et al.
Publicado: (2012)

IL18-containing 5-gene signature distinguishes histologically identical dermatomyositis and lupus erythematosus skin lesions
por: Tsoi, Lam C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dp6otjab41bru9pu304ic45ele